Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Fondazione Tettamanti
Sponsor

Fondazione Tettamanti

Italy Via Giovanni Battista Pergolesi 33, 20900 Monza, Italy

About the sponsor

Fondazione Tettamanti focuses on clinical research in B-cell precursor acute lymphoblastic leukemia, B-cell non-Hodgkin lymphoma, and chronic lymphocytic leukemia, with activity centered in Monza, Italy.

  • Relapsed/refractory leukemia
  • B-cell lymphoma
  • Chronic lymphocytic leukemia

The sponsored studies are concentrated on blood cancers with unmet treatment needs, particularly in patients requiring novel cellular therapies.

About Specializations

Fondazione Tettamanti runs clinical trials in conditions such as Chronic lymphocytic leukaemia refractory, Acute myeloid leukaemia, Blastic plasmacytoid dendritic cell neoplasia, Acute lymphocytic leukaemia, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

3 clinical trials

Chronic lymphocytic leukaemia refractory

Recruiting

Study on PTG-CARCIK-CD19 for Adults and Children with Relapsed or Refractory B-cell Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia

InvestigationalNo placebo
Countries:ItalyItaly
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Ptg-Carcik-Cd19
  • Sponsor:Fondazione Tettamanti

Acute myeloid leukaemia+1

Not yet recruiting

Safety and feasibility study of CARCIK‑CD123/33 cell therapy in adult and pediatric patients with relapsed or refractory AML and BPDCN

InvestigationalNo placebo
Countries:ItalyItaly
  • Participants:0–17 years · 18–64 years · 65+ years
  • Sponsor:Fondazione IRCCS San Gerardo Dei Tintori

Acute lymphocytic leukaemia

Not recruiting

Study of CARCIK-CD19 Cells for Patients with Relapsed or Refractory B Cell Precursor Acute Lymphoblastic Leukemia

InvestigationalNo placebo
Countries:ItalyItaly
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:CARCIK-CD19 cells
  • Sponsor:Fondazione Tettamanti

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.